Insulin-mediated regulation of the exocytosis of vesicles containing the glucose transporter GLUT4 has similarities to regulated synaptic transmission. A recent study has now identified a key regulated component of the fusion step in the exocytosis of these GLUT4-containing vesicles.
Insulin signalling in its target cells of adipose tissue and skeletal and cardiac muscle results in a massive stimulation of the movement of the glucose transporter GLUT4 from an intracellular storage compartment to the plasma membrane. This translocation process is critical for insulin-induced glucose uptake, because it produces a net increase in the number of glucose transporter molecules available at the plasma membrane. In the basal state virtually all of the GLUT4 molecules are sequestered intracellularly in a basal reservoir compartment [1] . Following insulin stimulation, these GLUT4-containing vesicles are rapidly exocytosed [2] . Understanding the mechanisms controlling the rapid exocytosis of GLUT4 is important because the pathogenesis of type 2 diabetes mellitus may be related to failures in the translocation of GLUT4 [3, 4] . A recent paper by Min et al. [5] describes a new component of the machinery involved in translocating GLUT4-containing vesicles termed Synip. This discovery focuses attention on the fusion of these vesicles with the plasma membrane as being the key regulated step in their exocytosis. This step has many similarities to regulated synaptic vesicle release and involves similar components.
GLUT4 vesicle transport and fusion machinery
Recent studies on the subcellular transport of GLUT4 have led to the characterisation of the machinery necessary for the sorting of this molecule into vesicular structures and the identification of the proteins necessary for fusion of these vesicles with the plasma membrane. Many of the components involved in synaptic vesicle transport, docking and fusion are now known to also be involved in the processing of GLUT4-containing vesicles [3] . These shared components include the N-ethylmaleimide-sensitive fusion (NSF) protein, which interacts with soluble NSF attachment proteins (SNAPs), and consequently with SNAP receptors or SNAREs. However, the details of the sequence of their participation and the mechanisms by which these processes are regulated are still being investigated.
Target SNAREs, or t-SNAREs, serve as the docking points for vesicles at the plasma membrane. Of the t-SNAREs, Syntaxin4 but not Syntaxins 1a, 1b or 3 can be detected in the plasma membrane of insulin-responsive cells, such as adipocytes and muscle cells [6] . An additional t-SNARE protein, SNAP23, is also present in the plasma membrane of these tissues [7] . An important Syntaxin4-binding protein found in insulin-responsive tissues is Munc18c [8] , a homologue of the neuronal proteins Munc18a and 18b and the yeast protein nSec1, which are implicated in the regulation of neuronal and yeast secretory pathways, respectively. Vesicle SNAREs, or v-SNAREs, interact with the t-SNAREs thereby docking the vesicle at the plasma membrane. The v-SNAREs of the synaptobrevin family VAMP2 (or synaptobrevin-2) and cellubrevin, but not synaptobrevin-1, are present in GLUT4-containing vesicles [6, 9] . These v-SNAREs in the GLUT4 vesicles and the t-SNAREs Syntaxin4 and SNAP23 from the plasma membrane of adipocytes have been found to form a complex with recombinant NSF and α-SNAP [6, 10] . Furthermore, insulin increases the amount of GLUT4 vesicle VAMP2 in the NSF-α-SNAP fusion complex [6] . These studies link Syntaxin4 with the docking reactions of the GLUT4-containing vesicles ( Figure 1 ).
Synip as a regulated fusion clamp
A key feature of synaptic transmission that distinguishes this process from constitutive membrane protein transport is the presence of 'fusion clamps' [11] that block vesicle fusion by reducing the availability of v-and t-SNAREs. The work by Min et al. [5] suggests that a fusion clamp may also act in the regulation of GLUT4 transport ( Figure 1 ). Syntaxin4 was used as a bait in a yeast twohybrid interaction screen to identify potential Syntaxin4-binding proteins. This screen led to the isolation of a cDNA that encoded a protein of 61 kDa, which they termed Synip (for Syntaxin4-interacting protein). Structural domain analysis of this protein revealed that it has an amino-terminal PDZ domain, followed by a potential calcium-binding EF-hand motif, two central coiled-coil domains and a WW domain close to the carboxyl terminus.
The distribution of Synip is particularly striking. It appears to be present in high amounts only in insulin-responsive tissues of skeletal muscle, heart and adipose tissue -those tissues where GLUT4 is also expressed. This observation is particularly important because the protein with which Synip interacts, Syntaxin4, is ubiquitously expressed. The restricted expression of Synip therefore provides the cell-type specificity of this interaction. Min et al. [5] were also able to demonstrate that insulin-treatment of cells led to around a 70% reduction in the amount of recombinant Synip bound to Syntaxin4. So, as with the fusion clamps in synaptic transmission, Synip seems to hold Syntaxin4 in an inactive state, preventing it from interacting with v-SNAREs.
Synip does not affect the interaction between Syntaxin4 and SNAP23, but it does reduce the interaction between Syntaxin4 and VAMP2. This feature led the authors to suggest a model for insulin action (Figure 1 ) in which the VAMP2 on GLUT4-containing vesicles can only dock with plasma membrane Syntaxin4 when Synip is released. In support of this hypothesis, they demonstrated that a carboxy-terminal portion of Synip can block insulin-stimulated glucose transport by around 50%. An amino-terminal region of Synip could not block insulin-stimulated transport, however. The implication is that signalling molecules interact with the amino-terminal section of Synip, possibly through the PDZ domain in this region, and this alters the conformation in the carboxy-terminal section and thereby weakens the interaction with Syntaxin4.
The link to insulin signalling
Studies on the mechanism by which insulin signalling leads to reduced interaction between Synip and Syntaxin4 are now likely to emerge rapidly. These studies will probably focus on the potential phosphorylation of Synip and related molecules. Syntaxin4 is known to be a substrate for protein kinase A and casein kinase II [12] whereas the Munc18 proteins are substrates for protein kinase C (PKC) [13] . Binding of Synip to Syntaxin4 or the Munc18 proteins may modify the accessibility of these phosphorylation sites. Another potential mechanism for insulin regulation may involve the amino-terminal PDZ domain of Synip. PDZ domains are known to be involved in generating protein scaffolds that include signalling intermediates such as protein tyrosine phosphatases and cytoskeletonbinding proteins. Again, parallels with synaptic transmission are evident -PDZ-domain-containing proteins at pre-synaptic membranes produce a scaffold of proteins in an 'active zone' of neurotransmitter release [14, 15] . An active zone and protein scaffold for regulated docking and fusion may therefore also be present in insulin-responsive tissues, in which case Synip and its binding partners would be key components of such a zone.
Studies on the GLUT4 docking and fusion mechanism and the scaffolding around this zone of fusion activity will ultimately lead back to the now well-characterised steps in early insulin signalling. These include the tyrosine kinase activity of the insulin receptor and its activation of phosphatidylinositol (PI) 3-kinase (Figure 2 ; for a review,
Figure 1
Docking and fusion of GLUT4-containing vesicles at the plasma membrane are dependent on interactions between v-and t-SNAREs and the activity of fusion clamps. It is postulated by Min et al. [5] that, following insulin signalling, Synip binding to Syntaxin4 is reduced. This process may be dependent on a PDZ-binding protein that interacts with the amino-terminal region of Synip and alters the conformation of its carboxy-terminal Syntaxin4-binding domain. This releases Syntaxin4 which can then interact with an additional t-SNARE (SNAP23) and the GLUT4 v-SNARE (VAMP2). Munc18c at the plasma membrane and a 20 kDa G protein of the Rab family on GLUT4 vesicles may also participate in the regulation of the vesicle fusion. see [16] ). PI 3-kinase isoforms produce several PI lipids including PI 3,4,5-trisphosphate (PIP 3 ), the 3,4 and 3,5 PI bisphosphates and the monophosphate PI 3-phosphate. Microinjection of an active form of the inositol 5′-phosphatase SHIP reduces cellular PIP 3 levels and GLUT4 translocation. This finding implies that PIP 3 may be the intermediate involved in interactions with downstream molecules in insulin signalling [17] , although the involvement of the other lipid products of PI 3-kinase has not been ruled out. Downstream molecules that interact with the inositol lipid products of PI 3-kinase include the serine kinase protein kinase B and the atypical PKC isoforms. Studies using constitutively active and dominantnegative forms of these enzymes have implicated their action in the regulation of GLUT4 translocation [18] [19] [20] [21] . Now that an insulin-regulated fusion process for GLUT4-containing vesicles has been identified, it should be possible to focus on the subset of PIP 3 -binding proteins and/or PIP 3 -regulated enzymes that impinge upon this step.
Finally, the drive towards further resolution of the mechanisms involved in insulin regulation of GLUT4 subcellular transport will lead to a greater understanding of the defect(s) in these processes that are responsible for type II diabetes. Will defective forms of Synip, Munc18c or one of their binding partners turn out to be a deadly pathogenic component?
